Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Hoth Therapeutics Signs Term Sheet with Zylö Therapeutics to Acquire a License and Jointly Develop a Product to Treat Lupus
Wednesday, May 15, 2019Hoth Therapeutics Inc a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitisalso known as eczemaas well as dermatological and chronic wound disorders today announced that...
Onconova Therapeutics Announces License Agreement with HanX Biopharmaceuticals to Develop and Commercialize Rigosertib in Greater China
Tuesday, May 14, 2019Onconova Therapeutics Inc a Phase stage biopharmaceutical company focused on discovering and developing novel products to treat cancer with an initial focus on myelodysplastic syndromes MDS today announced that it has entered into a license agreement...
Titan Pharmaceuticals Further Expands Patient Access To Probuphine® Via Product Purchase And Supply Agreement With Express Scripts' Specialty Pharmacy, Accredo®
Tuesday, May 14, 2019Titan Pharmaceuticals Inc today announced that it has executed a product purchase and supply agreement with Accredo specialty pharmacy a subsidiary of Express Scripts further expanding access to treatment with Probuphine buprenorphine implant Titans...
Forty Seven Inc. and Acerta Enter Collaboration to Evaluate Novel Immuno-Oncology Triple Combination in Diffuse Large B-cell Lymphoma
Monday, May 13, 2019Forty Seven Inc a clinicalstage immunooncology company focused on developing therapies to activate macrophages in the fight against cancer today announced a collaboration with Acerta Pharma AstraZenecas hematology research and development center of e...
C3J Therapeutics and AmpliPhi Biosciences Announce Successful Completion of Merger and Formation of Bacteriophage Company Armata Pharmaceuticals, Inc.
Friday, May 10, 2019Armata Pharmaceuticals Inc a clinicalstage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibioticresistant infections today announced that the previouslyannounced merger between CJ Therapeutics Inc CJ and AmpliP...
Bayer Invests $150 Million to Build New Cell Culture Technology Center in Berkeley to Spur Innovation of Biotech Therapies
Friday, May 10, 2019Bayer announced today it will invest million in its Berkeley CA pharmaceutical development and manufacturing site to build a Cell Culture Technology Center that will be used to accelerate the development of biological therapies Once complete the new...
Adimab Announces Multi-Target Expansion for the Discovery of Antibodies with Another Global Pharma Partner
Thursday, May 09, 2019Adimab LLC the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies announced the expansion of an earlier partnership with Novartis Adimab will use its proprietary platform to discover and optimize antib...
Adimab Expands Research Agreement with Regeneron
Thursday, May 09, 2019Adimab LLC the leading provider of antibody discovery and optimization technology today announced the expansion of an earlier multitarget research agreement with Regeneron Pharmaceuticals
WuXi AppTec Acquires Pharmapace to Enhance Biometrics Services for Clinical Development
Monday, May 06, 2019WuXi AppTec a leading global pharmaceutical and medical device openaccess capability and technology platform company today announced that it has acquired Pharmapace Inc a USbased clinical research services company with expertise of providing high qua...
Arcus Biosciences and Strata Oncology Announce Clinical Development Collaboration for Anti-PD-1 Antibody AB122
Friday, May 03, 2019Arcus Biosciences Inc a clinicalstage biopharmaceutical company focused on creating innovative cancer immunotherapies and Strata Oncology Inc Strata a precision oncology company today announced that the companies have entered into a clinical developm...